Navigation Links
Lumbar Matrix(TM) Scan From SpineMatrix(R) Revolutionizes the Diagnosis of Low Back Pain
Date:6/10/2009

Accurately Locates the Origin of Pain While Reducing Healthcare Costs

AKRON, Ohio, June 10 /PRNewswire/ -- A new technology that revolutionizes the way low back pain is diagnosed and treated, while also significantly reducing healthcare costs, has been introduced by SpineMatrix(R) Inc., an Akron, Ohio-based medical technology company that specializes in advanced spinal diagnostics.

SpineMatrix's new, non-invasive Lumbar Matrix(TM) Scan uses high-speed computer processing of thousands of bioelectric signals to observe neuromuscular activity of the low back. The advanced diagnostic technology allows physicians to accurately identify the source of low back pain, which helps determine proper treatment and can result in significant savings for patients and the healthcare industry.

Low back pain is the most common and costly disabling condition in the United States, affecting nearly 31 million Americans. Current diagnostic methods used most frequently to detect lower back pain - such as X-rays, magnetic resonance imaging (MRI) and computed tomography (CT) scans - take into account the anatomy of the back but not the physiology. These methods often fail to pinpoint the precise cause of pain for this reason. More than 85 percent of patients with low back pain are never given a specific diagnosis, leading to ineffective treatment and billions of dollars spent in unnecessary healthcare costs. Additionally, invasive procedures, including surgery, may follow misdiagnosed lower back pain, further elevating healthcare spending. Since 1997, U.S. spending on diagnosis and treatment of spinal disorders increased 65 percent, as indicated by the Journal of the American Medical Association.

"The Lumbar Matrix Scan was developed to help physicians more precisely diagnose the cause of low back pain and prescribe the best form of treatment to alleviate the pain," said Ben Shappley, president and
'/>"/>

SOURCE SpineMatrix Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. RSB Spine, LLC Announces First Implantation of the InterPlate(TM) L for the Lumbar Spine
2. Siemens New S Class Revolutionizes the Paradigm of Ultrasound Workflow Today and Tomorrow
3. A New Era in the Application of Lab-on-a-Chip to Rapid Point-of-Care Diagnosis
4. SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Germany & Austria
5. Transforming medical diagnosis with new scanning technology
6. Further 100 Million Euros Allocated to Netherlands-Based R&D Targeting the Early Diagnosis and Treatment of Disease
7. International Guidelines for First-Line use of Freelite(TM) in Diagnosis and Management of Multiple Myeloma to be Published in "Leukemia"
8. In 2008, Ipsogen Reinforced its Leadership in Molecular Diagnosis and Monitoring of Leukemia
9. deCODE Study Expands Clinical Utility of deCODE AF(TM) for Improving the Diagnosis of Atrial Fibrillation and Preventing Stroke
10. SpectraScience Awarded Patent for Its Optical Biopsy System and Methods for Tissue Diagnosis
11. University of Southern California Receives Cancer Diagnosis System for Detecting Esophageal Dysplasia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , Sept. 2, 2015 Australian prostate ... a prestigious Australian science prize recognising ,outstanding, science that ... track to globally launch a novel prostate cancer diagnostic ... a high level consortium taking out the peer-reviewed Australian ... Scientific Research. This prize is awarded ...
(Date:9/2/2015)... Colo. , Sept. 2, 2015 Aytu ... on developing treatments for urological and related conditions, announced ... its planned private placement convertible note financing, raising a ... prior tranches totaling $3.175 million. ... "Proceeds from this private placement are intended to be ...
(Date:9/2/2015)... FRANCISCO, Calif. , Sept. 2, 2015 ... Bonnie H. Anderson , president and chief executive ... Conference on Wednesday, September 16, 2015 at 10:30 a.m. ... The live audio webcast and subsequent ... . The webcast will be available shortly after conclusion ...
(Date:9/2/2015)... , September 2, 2015 ... ("BioLight" or the "Company"), a firm that invests ... and cancer diagnostics, announced today that presentations highlighting ... will be delivered at the Ophthalmology Futures European ... Society of Cataract & Refractive Surgeons ("ESCRS"), both ...
Breaking Biology Technology:Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 2Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 3Aytu BioScience Completes $5.175 Million Private Placement 2Aytu BioScience Completes $5.175 Million Private Placement 3Veracyte to Present at Morgan Stanley Global Healthcare Conference 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 3
... Calif., Nov. 5 Onyx,Pharmaceuticals, Inc. (Nasdaq: ... the 2008 Credit Suisse Health Care Conference on ... a.m. Pacific Time). Interested parties,may access a live ... http://www.onyx-pharm.com/wt/page/event_calendar , It is recommended that listeners ...
... ... - - Quantitative HER2 Scores Now Included in All Oncotype DX Reports - ... - Conference Call Today at 4:30 p.m. ET -, REDWOOD CITY, Calif., Nov. ... progress,for the quarter ended September 30, 2008., Total revenue increased to $28.1 million ...
... /PRNewswire-FirstCall/ - Dr. Brad Thompson, President,and CEO of Oncolytics ... and webcast on Thursday, November 6, 2008 at,11:00 a.m. ... trial results,in its U.S. Phase II trial for patients ... The results are scheduled to be presented November,6, 2008 ...
Cached Biology Technology:Genomic Health Announces Third Quarter 2008 Financial Results and Business Progress 2Genomic Health Announces Third Quarter 2008 Financial Results and Business Progress 3Genomic Health Announces Third Quarter 2008 Financial Results and Business Progress 4Genomic Health Announces Third Quarter 2008 Financial Results and Business Progress 5Genomic Health Announces Third Quarter 2008 Financial Results and Business Progress 6Genomic Health Announces Third Quarter 2008 Financial Results and Business Progress 7Genomic Health Announces Third Quarter 2008 Financial Results and Business Progress 8Oncolytics Biotech Inc. Announces U.S. Phase II Sarcoma Clinical Trial Conference Call 2
(Date:8/20/2015)... ., Aug. 20, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market ... has joined The Smart Card Alliance and the EMV ... Alliance and the Smart Card Alliance Latin America (SCALA) ... industry peers and thought leaders promoting adoption of smart ...
(Date:8/12/2015)... Aug. 12, 2015   MedNet Solutions , an ... spectrum of clinical research, is proud to announce that ... comprehensive SaaS-based eClinical technology platform, has led the way ... two quarters of 2015.   Q2 2015 and Q1 ... measured by contract value sold in the company,s 15 ...
(Date:8/10/2015)... and TELTOW, Germany , August ... (SMI), a world leader in Eye Tracking Technology ... of its OEM Eye Tracking Platform for integration into ... Platform contains reference designs for seamless integration of eye ... virtual reality HMDs and augmented reality smart glasses. Omnivision,s ...
Breaking Biology News(10 mins):NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 2NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 3NXT-ID, Inc. Joins Smart Card Alliance and EMV Migration Forum 4MedNet Solutions Experiences Explosive Corporate Growth 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3
... bird in hand is worth two in the bush may ... the lab of ASU School of Life Sciences Professor Roy ... at the Biodesign Institute. There, associate research scientist ... targets to develop a vaccine against a leading poultry disease, ...
... working gene is inserted into a cell to replace a ... the prevention and treatment of disease. Now a ... a counterintuitive approach also holds promise. The targeted removal of ... would do -- can restore cellular function in cells with ...
... United Kingdom and France have identified four separate ... Creutzfeldt-Jakob disease. The study, published March 14th in ... subgroups could represent distinct prion strains in what ... Prion diseases are transmissible neurodegenerative disorders characterized by ...
Cached Biology News:Solving an avian scourge could also provide benefits to human health 2Solving an avian scourge could also provide benefits to human health 3Work with power grids leads to cell biology discovery 2Work with power grids leads to cell biology discovery 3
... Synthetic peptide derived from the C-terminal region ... kinase C zeta isoform (PKCzeta). Specificity: ... protein. Recognizes PKCzeta and PKMzeta (PKCzeta ... Reactivity: Mouse Rat (positive controls: mouse ...
Request Info...
Streptomycin sulfate an aminoglycoside used for bacterial selection binds to the small ribosomal subunit and interferes with protein biosynthesis.21H39N7O12)2x3H2SO4Formula weight:...
...
Biology Products: